insights_auto
Why is SGMOQ down 2.11%?
Dive Deeperchevron_right
SGMOQ:OTCMKTS
Sangamo Therapeutics Inc
$0.14
arrow_downward
-2.11%(-0.0031) 1D
Sep 25, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SGMOQ...
Open
$0.15
High
$0.15
Low
$0.14
Mkt. cap
58.50M
Avg. vol.
2.81M
Volume
1.75M
52-wk high
$0.20
52-wk low
$0.03
EPS
-$0.38
Beta
1.55
Shares outstanding
414.29M
No. of employees
142
Open
$0.15
High
$0.15
Low
$0.14
Mkt. cap
58.50M
Avg. vol.
2.81M
Volume
1.75M
52-wk high
$0.20
52-wk low
$0.03
EPS
-$0.38
Beta
1.55
Shares outstanding
414.29M
No. of employees
142
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 month ago
SGMO Q1 2026 Earnings: Wide EPS Miss Highlights Operating Pressure as Shares Hold Steady - Mid-Term Outlook
Profile
Sangamo Therapeutics, Inc. is an American biotechnology company based in Richmond, California, that develops cell and gene therapies for severe genetic diseases. Wikipedia
About Sangamo Therapeutics Inc
CEOSandy Macrae
Employees142
Founded1995
HeadquartersRichmond, California, United States
SectorBiotechnology
Websitesangamo.com